Alcobra Ltd.
Records under this name other than patents Alcobra Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 10 of 10 · Back to Alcobra Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,931,303 | Abuse Deterrent Formulations of Amphetamine Formerly held In force · High confidence | In force | High confidence | |
| US 10,471,015 | Abuse Deterrent Formulations of Amphetamine Formerly held In force · High confidence | In force | High confidence | |
| US 11,517,537 | Abuse Deterrent Formulations of Amphetamine Formerly held In force · High confidence | In force | High confidence | |
| US 9,851,354 | Methods of treating fragile X syndrome and related disorders Lapsed on the fee record Ended Dec 26, 2021 · From the USPTO record | Lapsed on the fee record | Ended Dec 26, 2021 | From the USPTO record |
| US 9,851,355 | Methods of determining response to therapy Lapsed on the fee record Ended Dec 26, 2021 · From the USPTO record | Lapsed on the fee record | Ended Dec 26, 2021 | From the USPTO record |
| US 9,808,446 | Method for Decreasing Symptoms of Alcohol Consumption Lapsed on the fee record Ended Nov 7, 2021 · Medium confidence | Lapsed on the fee record | Ended Nov 7, 2021 | Medium confidence |
| US 8,476,304 | Method for Decreasing Symptoms of Alcohol Consumption Lapsed on the fee record Ended Jul 2, 2021 · Medium confidence | Lapsed on the fee record | Ended Jul 2, 2021 | Medium confidence |
| US 9,428,458 | Substituted pyridoxine-lactam carboxylate-salts Lapsed on the fee record Ended Aug 30, 2020 · From the USPTO record | Lapsed on the fee record | Ended Aug 30, 2020 | From the USPTO record |
| US 8,889,715 | Substituted pyridoxine-lactam carboxylate salts Lapsed on the fee record Ended Nov 18, 2018 · From the USPTO record | Lapsed on the fee record | Ended Nov 18, 2018 | From the USPTO record |
| US 8,710,067 | Method for the treatment, alleviation of symptoms of, relieving, improving and preventing a cognitive disease, disorder or condition Lapsed on the fee record Ended Apr 29, 2018 · From the USPTO record | Lapsed on the fee record | Ended Apr 29, 2018 | From the USPTO record |